Trial Outcomes & Findings for An Interactive Gaming-based Intervention for Back Pain (NCT NCT02503410)
NCT ID: NCT02503410
Last Updated: 2019-05-28
Results Overview
Subjects are asked to indicate their pain level using a visual analog scale, namely they are asked to choose the position on a horizontal line - drawn on a piece of paper - that corresponds to the pain level that they experience. The line is about 10 cm long and is divided into 10 intervals of equal length referred to as units. The minimum value on the scale is zero (meaning no pain). The maximum value on the scale is ten (meaning maximum ever experienced pain).
TERMINATED
NA
7 participants
Change from baseline in Visual Analogue Pain Scale score at 4 weeks
2019-05-28
Participant Flow
Subjects were recruited primarily among the outpatient population of individuals with low back pain at Spaulding Rehabilitation Hospital.
Participant milestones
| Measure |
Usual Care
Subjects receive physical therapy for low back pain as typically prescribed in the clinic.
|
Interactive Gaming
Subjects participate in an intervention combining usual care and home-based exercises using the Valedo system.
|
|---|---|---|
|
Overall Study
STARTED
|
4
|
3
|
|
Overall Study
COMPLETED
|
4
|
3
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
An Interactive Gaming-based Intervention for Back Pain
Baseline characteristics by cohort
| Measure |
Usual Care
n=4 Participants
Subjects receive physical therapy for low back pain as typically prescribed in the clinic.
|
Interactive Gaming
n=3 Participants
Subjects participate in an intervention combining usual care and home-based exercises using the Valedo system.
|
Total
n=7 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
36.8 years
STANDARD_DEVIATION 10.4 • n=5 Participants
|
31.7 years
STANDARD_DEVIATION 3.8 • n=7 Participants
|
34.6 years
STANDARD_DEVIATION 8.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
4 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Visual Analog Pain Scale
|
3.5 units on a scale
STANDARD_DEVIATION 1.3 • n=5 Participants
|
4.0 units on a scale
STANDARD_DEVIATION 1.0 • n=7 Participants
|
3.7 units on a scale
STANDARD_DEVIATION 1.1 • n=5 Participants
|
|
Pain Frequency
|
5.3 days
STANDARD_DEVIATION 0.9 • n=5 Participants
|
6.0 days
STANDARD_DEVIATION 1.7 • n=7 Participants
|
5.8 days
STANDARD_DEVIATION 1.2 • n=5 Participants
|
PRIMARY outcome
Timeframe: Change from baseline in Visual Analogue Pain Scale score at 4 weeksSubjects are asked to indicate their pain level using a visual analog scale, namely they are asked to choose the position on a horizontal line - drawn on a piece of paper - that corresponds to the pain level that they experience. The line is about 10 cm long and is divided into 10 intervals of equal length referred to as units. The minimum value on the scale is zero (meaning no pain). The maximum value on the scale is ten (meaning maximum ever experienced pain).
Outcome measures
| Measure |
Usual Care Group
n=4 Participants
physical therapy (as prescribed during 8 to 12 weeks) and home exercises (at least 2x/week)
Home-based exercises: Subjects will receive a combination of physical therapy and home exercise program during 8 to 12 weeks. Home exercise will be recommended at least two times a week. Usual Care of LBP provided in SRH consists of exercises and manual therapy in various combinations according to the needs of the subject. Subjects will fill out a questionnaire about their pain and how much time they spent doing the home exercises every two weeks.
|
Interactive Home-Based System Group
n=3 Participants
physical therapy (as prescribed during 8 to 12 weeks) and interactive exercises program at home with the Valedo® System (Hocoma AG) (at least 2x/week)
Interactive gaming home-based exercises: Subjects will receive a combination of physical therapy (during 8 to 12 weeks) and at least two sessions of interactive exercises program at home with the Valedo® System (Hocoma AG). Subjects will fill out a questionnaire about their pain every two weeks during the treatment period.
Valedo® System (Hocoma AG)
|
|---|---|---|
|
Visual Analogue Pain Scale at 4 Weeks
|
0.0 units on a scale
Standard Deviation 0.8
|
0.3 units on a scale
Standard Deviation 1.2
|
PRIMARY outcome
Timeframe: Change from baseline in VAS score at 8 weeksSubjects are asked to indicate their pain level using a visual analog scale, namely they are asked to choose the position on a horizontal line - drawn on a piece of paper - that corresponds to the pain level that they experience. The line is about 10 cm long and is divided into 10 intervals of equal length referred to as units. The minimum value on the scale is zero (meaning no pain). The maximum value on the scale is ten (meaning maximum ever experienced pain).
Outcome measures
| Measure |
Usual Care Group
n=4 Participants
physical therapy (as prescribed during 8 to 12 weeks) and home exercises (at least 2x/week)
Home-based exercises: Subjects will receive a combination of physical therapy and home exercise program during 8 to 12 weeks. Home exercise will be recommended at least two times a week. Usual Care of LBP provided in SRH consists of exercises and manual therapy in various combinations according to the needs of the subject. Subjects will fill out a questionnaire about their pain and how much time they spent doing the home exercises every two weeks.
|
Interactive Home-Based System Group
n=3 Participants
physical therapy (as prescribed during 8 to 12 weeks) and interactive exercises program at home with the Valedo® System (Hocoma AG) (at least 2x/week)
Interactive gaming home-based exercises: Subjects will receive a combination of physical therapy (during 8 to 12 weeks) and at least two sessions of interactive exercises program at home with the Valedo® System (Hocoma AG). Subjects will fill out a questionnaire about their pain every two weeks during the treatment period.
Valedo® System (Hocoma AG)
|
|---|---|---|
|
Visual Analogue Pain Scale at 8 Weeks
|
0.2 units on a scale
Standard Deviation 1.7
|
1.3 units on a scale
Standard Deviation 1.2
|
PRIMARY outcome
Timeframe: Change in pain frequency at 4 weeksSubjects are asked how many days they experienced low back pain during the week prior to the study visit.
Outcome measures
| Measure |
Usual Care Group
n=4 Participants
physical therapy (as prescribed during 8 to 12 weeks) and home exercises (at least 2x/week)
Home-based exercises: Subjects will receive a combination of physical therapy and home exercise program during 8 to 12 weeks. Home exercise will be recommended at least two times a week. Usual Care of LBP provided in SRH consists of exercises and manual therapy in various combinations according to the needs of the subject. Subjects will fill out a questionnaire about their pain and how much time they spent doing the home exercises every two weeks.
|
Interactive Home-Based System Group
n=3 Participants
physical therapy (as prescribed during 8 to 12 weeks) and interactive exercises program at home with the Valedo® System (Hocoma AG) (at least 2x/week)
Interactive gaming home-based exercises: Subjects will receive a combination of physical therapy (during 8 to 12 weeks) and at least two sessions of interactive exercises program at home with the Valedo® System (Hocoma AG). Subjects will fill out a questionnaire about their pain every two weeks during the treatment period.
Valedo® System (Hocoma AG)
|
|---|---|---|
|
Pain Frequency at 4 Weeks
|
2.5 days
Standard Deviation 2.4
|
-0.3 days
Standard Deviation 0.6
|
PRIMARY outcome
Timeframe: Change in pain frequency at 8 weeksSubjects are asked how many days they experienced low back pain during the week prior to the study visit.
Outcome measures
| Measure |
Usual Care Group
n=4 Participants
physical therapy (as prescribed during 8 to 12 weeks) and home exercises (at least 2x/week)
Home-based exercises: Subjects will receive a combination of physical therapy and home exercise program during 8 to 12 weeks. Home exercise will be recommended at least two times a week. Usual Care of LBP provided in SRH consists of exercises and manual therapy in various combinations according to the needs of the subject. Subjects will fill out a questionnaire about their pain and how much time they spent doing the home exercises every two weeks.
|
Interactive Home-Based System Group
n=3 Participants
physical therapy (as prescribed during 8 to 12 weeks) and interactive exercises program at home with the Valedo® System (Hocoma AG) (at least 2x/week)
Interactive gaming home-based exercises: Subjects will receive a combination of physical therapy (during 8 to 12 weeks) and at least two sessions of interactive exercises program at home with the Valedo® System (Hocoma AG). Subjects will fill out a questionnaire about their pain every two weeks during the treatment period.
Valedo® System (Hocoma AG)
|
|---|---|---|
|
Pain Frequency at 8 Weeks
|
-0.2 days
Standard Deviation 2.1
|
0.0 days
Standard Deviation 0.0
|
SECONDARY outcome
Timeframe: Change in disability score at 4 weeksSubjects are asked to fill in a questionnaire inquiring about how their pain interferes with their activities of daily living. Accordingly, they receive a disability score ranging between 0 and 100%. A score between 0 and 20% indicates minimal disability; a score between 21 and 40% indicates moderate disability; a score between 41 and 60% indicates severe disability; a score between 61 and 80% indicates that pain impinges on all aspects of the patient's life; and score between 81 and 100% indicates that the subject is bed-bound.
Outcome measures
| Measure |
Usual Care Group
n=4 Participants
physical therapy (as prescribed during 8 to 12 weeks) and home exercises (at least 2x/week)
Home-based exercises: Subjects will receive a combination of physical therapy and home exercise program during 8 to 12 weeks. Home exercise will be recommended at least two times a week. Usual Care of LBP provided in SRH consists of exercises and manual therapy in various combinations according to the needs of the subject. Subjects will fill out a questionnaire about their pain and how much time they spent doing the home exercises every two weeks.
|
Interactive Home-Based System Group
n=3 Participants
physical therapy (as prescribed during 8 to 12 weeks) and interactive exercises program at home with the Valedo® System (Hocoma AG) (at least 2x/week)
Interactive gaming home-based exercises: Subjects will receive a combination of physical therapy (during 8 to 12 weeks) and at least two sessions of interactive exercises program at home with the Valedo® System (Hocoma AG). Subjects will fill out a questionnaire about their pain every two weeks during the treatment period.
Valedo® System (Hocoma AG)
|
|---|---|---|
|
Oswestry Low Back Pain Disability Questionnaire at 4 Weeks
|
1.0 percentage disability
Standard Deviation 3.5
|
4.7 percentage disability
Standard Deviation 4.6
|
SECONDARY outcome
Timeframe: Change in disability score at 8 weeksSubjects are asked to fill in a questionnaire inquiring about how their pain interferes with their activities of daily living. Accordingly, they receive a disability score ranging between 0 and 100%. A score between 0 and 20% indicates minimal disability; a score between 21 and 40% indicates moderate disability; a score between 41 and 60% indicates severe disability; a score between 61 and 80% indicates that pain impinges on all aspects of the patient's life; and score between 81 and 100% indicates that the subject is bed-bound.
Outcome measures
| Measure |
Usual Care Group
n=4 Participants
physical therapy (as prescribed during 8 to 12 weeks) and home exercises (at least 2x/week)
Home-based exercises: Subjects will receive a combination of physical therapy and home exercise program during 8 to 12 weeks. Home exercise will be recommended at least two times a week. Usual Care of LBP provided in SRH consists of exercises and manual therapy in various combinations according to the needs of the subject. Subjects will fill out a questionnaire about their pain and how much time they spent doing the home exercises every two weeks.
|
Interactive Home-Based System Group
n=3 Participants
physical therapy (as prescribed during 8 to 12 weeks) and interactive exercises program at home with the Valedo® System (Hocoma AG) (at least 2x/week)
Interactive gaming home-based exercises: Subjects will receive a combination of physical therapy (during 8 to 12 weeks) and at least two sessions of interactive exercises program at home with the Valedo® System (Hocoma AG). Subjects will fill out a questionnaire about their pain every two weeks during the treatment period.
Valedo® System (Hocoma AG)
|
|---|---|---|
|
Oswestry Low Back Pain Disability Questionnaire at 8 Weeks
|
12.7 percentage disability
Standard Deviation 10.6
|
11.3 percentage disability
Standard Deviation 7.0
|
SECONDARY outcome
Timeframe: Change in clinical score at 4 weeksThe SF36 is a clinical outcome measure based on the administration of a questionnaire inquiring about the quality of life and health status of the subject. It consists of eight normalized (so that they have the some weight) scores related to vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health. The lower the score the more disability. The higher the score the less disability. The score is provide as units on a scale from 0 to 100.
Outcome measures
| Measure |
Usual Care Group
n=4 Participants
physical therapy (as prescribed during 8 to 12 weeks) and home exercises (at least 2x/week)
Home-based exercises: Subjects will receive a combination of physical therapy and home exercise program during 8 to 12 weeks. Home exercise will be recommended at least two times a week. Usual Care of LBP provided in SRH consists of exercises and manual therapy in various combinations according to the needs of the subject. Subjects will fill out a questionnaire about their pain and how much time they spent doing the home exercises every two weeks.
|
Interactive Home-Based System Group
n=3 Participants
physical therapy (as prescribed during 8 to 12 weeks) and interactive exercises program at home with the Valedo® System (Hocoma AG) (at least 2x/week)
Interactive gaming home-based exercises: Subjects will receive a combination of physical therapy (during 8 to 12 weeks) and at least two sessions of interactive exercises program at home with the Valedo® System (Hocoma AG). Subjects will fill out a questionnaire about their pain every two weeks during the treatment period.
Valedo® System (Hocoma AG)
|
|---|---|---|
|
SF36 at 4 Weeks
|
2.6 units on a scale
Standard Deviation 14.6
|
6.6 units on a scale
Standard Deviation 11.2
|
SECONDARY outcome
Timeframe: Change in clinical score at 8 weeksThe SF36 is a clinical outcome measure based on the administration of a questionnaire inquiring about the quality of life and health status of the subject. It consists of eight normalized (so that they have the some weight) scores related to vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health. The lower the score the more disability. The higher the score the less disability. The score is provide as units on a scale from 0 to 100
Outcome measures
| Measure |
Usual Care Group
n=4 Participants
physical therapy (as prescribed during 8 to 12 weeks) and home exercises (at least 2x/week)
Home-based exercises: Subjects will receive a combination of physical therapy and home exercise program during 8 to 12 weeks. Home exercise will be recommended at least two times a week. Usual Care of LBP provided in SRH consists of exercises and manual therapy in various combinations according to the needs of the subject. Subjects will fill out a questionnaire about their pain and how much time they spent doing the home exercises every two weeks.
|
Interactive Home-Based System Group
n=3 Participants
physical therapy (as prescribed during 8 to 12 weeks) and interactive exercises program at home with the Valedo® System (Hocoma AG) (at least 2x/week)
Interactive gaming home-based exercises: Subjects will receive a combination of physical therapy (during 8 to 12 weeks) and at least two sessions of interactive exercises program at home with the Valedo® System (Hocoma AG). Subjects will fill out a questionnaire about their pain every two weeks during the treatment period.
Valedo® System (Hocoma AG)
|
|---|---|---|
|
SF36 at 8 Weeks
|
13.2 units on a scale
Standard Deviation 6.1
|
9.5 units on a scale
Standard Deviation 15.7
|
Adverse Events
Usual Care
Interactive Gaming
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place